BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shu H, Peng Y, Hang W, Zhou N, Wang DW. Trimetazidine in Heart Failure. Front Pharmacol 2020;11:569132. [PMID: 33597865 DOI: 10.3389/fphar.2020.569132] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Belenichev IF, Bak PG, Popazova OO, Bukhtiyarova NV, Yadlovsky OE. Nitric oxide-dependent mechanism of endothelial dysfunction formation is a promising target link for pharmacological management. Biopolym Cell 2022;38:145-157. [DOI: 10.7124/bc.000a79] [Reference Citation Analysis]
2 Kalyuzhin VV, Teplyakov AT, Bespalova ID, Kalyuzhina EV, Terentyeva NN, Grakova EV, Kopeva KV, Usov VY, Garganeeva NP, Pavlenko OA, Gorelova YV, Teteneva AV. Promising directions in the treatment of chronic heart failure: improving old or developing new ones? Bûll sib med 2022;21:181-197. [DOI: 10.20538/1682-0363-2022-3-181-197] [Reference Citation Analysis]
3 Jedrzejewska A, Braczko A, Kawecka A, Hellmann M, Siondalski P, Slominska E, Kutryb-zajac B, Yacoub MH, Smolenski RT. Novel Targets for a Combination of Mechanical Unloading with Pharmacotherapy in Advanced Heart Failure. IJMS 2022;23:9886. [DOI: 10.3390/ijms23179886] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Al-Kuraishy HM, Al-Gareeb AI, Welson NN, Batiha GE. Trimetazidine and COVID-19-induced acute cardiac injury: a missed key. Int J Clin Pharm 2022. [PMID: 35449348 DOI: 10.1007/s11096-022-01408-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
5 Bubnova MG, Aronov DM. Efficacy of trimetazidine – an inhibitor of free fatty acids oxidation in the treatment of patients with stable angina pectoris and heart failure. Kardiologiia 2021;61:65-76. [DOI: 10.18087/cardio.2021.11.n1801] [Reference Citation Analysis]
6 Avagimyan A, Mkrtchyan L, Abrahomovich O, Sheibani M, Guevorkyan A, Sarrafzadegan N, Kozhukhov S, Agati L, Astengiano R, Zaritska V, Jndoyan Z. AC-Mode of Chemotherapy as a Trigger of Cardiac Syndrome X: A Case Study. Curr Probl Cardiol 2021;:100994. [PMID: 34571104 DOI: 10.1016/j.cpcardiol.2021.100994] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Luo XY, Zhong Z, Chong AG, Zhang WW, Wu XD. Function and Mechanism of Trimetazidine in Myocardial Infarction-Induced Myocardial Energy Metabolism Disorder Through the SIRT1-AMPK Pathway. Front Physiol 2021;12:645041. [PMID: 34220528 DOI: 10.3389/fphys.2021.645041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]